I also think the FDA approval is not a game changer (since the so called " Bronchitol business restructure" did not happen) for the share price, unless Chiesi can do a magical sale figure in US market.
There is a chance, although remote, that the LOXL2 deal can be announced. But 2+ years already since Gary Philips bragging the drug has drawn huge interests from big pharams, I doubt this is going to happen at all.
Bone cancer is a new, cool and fancy story, which I guess will last a year or two for these guys enjoying the shareholders' money for their salary and bonus,
Show the deal and show the money Gary, or you are nothing but a liar.
I also think the FDA approval is not a game changer (since the...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SNT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $28.65M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 208000 | 2.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.4¢ | 175952 | 2 |
View Market Depth
| Last trade - 09.35am 25/06/2024 (20 minute delay) ? |
| SNT (ASX) Chart |
Day chart unavailable